A number of studies have shown that pedigrees with germline mutations in ATM, BRCA1, and BRCA2 also have an increased lifetime risk of pancreatic cancer in familial pancreatic cancer (FPC) kindreds [103,162,163,164,165,166]. This evidence concerns the gene BRCA2 and pancreatic neoplasm.